Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial

F Sandri, G Ancora, A Lanzoni, P Tagliabue, M Colnaghi, M L Ventura, M Rinaldi, I Mondello, P Gancia, G P Salvioli, M Orzalesi, F Mosca, F Sandri, G Ancora, A Lanzoni, P Tagliabue, M Colnaghi, M L Ventura, M Rinaldi, I Mondello, P Gancia, G P Salvioli, M Orzalesi, F Mosca

Abstract

Background: The role of nasal continuous positive airways pressure (nCPAP) in the management of respiratory distress syndrome in preterm infants is not completely defined.

Objective: To evaluate the benefits and risks of prophylactic nCPAP in infants of 28-31 weeks gestation.

Design: Multicentre randomised controlled clinical trial.

Setting: Seventeen Italian neonatal intensive care units.

Patients: A total of 230 newborns of 28-31 weeks gestation, not intubated in the delivery room and without major malformations, were randomly assigned to prophylactic or rescue nCPAP.

Interventions: Prophylactic nCPAP was started within 30 minutes of birth, irrespective of oxygen requirement and clinical status. Rescue nCPAP was started when Fio2 requirement was > 0.4, for more than 30 minutes, to maintain transcutaneous oxygen saturation between 93% and 96%. Exogenous surfactant was given when Fio2 requirement was > 0.4 in nCPAP in the presence of radiological signs of respiratory distress syndrome.

Main outcome measures: Primary end point: need for exogenous surfactant. Secondary end points: need for mechanical ventilation and incidence of air leaks.

Results: Surfactant was needed by 22.6% in the prophylaxis group and 21.7% in the rescue group. Mechanical ventilation was required by 12.2% in both the prophylaxis and rescue group. The incidence of air leaks was 2.6% in both groups. More than 80% of both groups had received prenatal steroids.

Conclusions: In newborns of 28-31 weeks gestation, there is no greater benefit in giving prophylactic nCPAP than in starting nCPAP when the oxygen requirement increases to a Fio2 > 0.4.

Figures

Figure 1
Figure 1
Flow diagram of eligible newborns. The number of infants not randomised and the reasons for non-enrolment are provided. Two infants in the prophylaxis group did not receive the allocated treatment (both infants requiring surfactant were firstly mechanically ventilated and then given surfactant). Statistical analysis was by "intention to treat".

References

    1. Eur J Pediatr. 2000 Apr;159(4):289-92
    1. Arch Dis Child Fetal Neonatal Ed. 1999 Sep;81(2):F152-6
    1. Pediatrics. 2001 Feb;107(2):304-8
    1. Pediatrics. 2001 Sep;108(3):682-5
    1. J Radiol Electrol Med Nucl. 1970 May;51(5):259-68
    1. N Engl J Med. 1971 Jun 17;284(24):1333-40
    1. Pediatrics. 1973 Jul;52(1):131-4
    1. Arch Dis Child. 1974 Mar;49(3):228-30
    1. Early Hum Dev. 1987 Jan;15(1):21-32
    1. Acta Paediatr Scand. 1990 Jun-Jul;79(6-7):581-6
    1. Behav Brain Res. 1992 Jul 31;49(1):1-6
    1. Acta Paediatr. 1993 Nov;82(11):934-8
    1. Pediatrics. 1994 May;93(5):737-46
    1. Acta Paediatr. 1994 Feb;83(2):143-9
    1. N Engl J Med. 1994 Oct 20;331(16):1051-5
    1. Acta Paediatr. 1995 Jun;84(6):613-6
    1. Arch Dis Child Fetal Neonatal Ed. 1995 Jul;73(1):F32-6
    1. JAMA. 1996 Feb 21;275(7):539-44
    1. Pediatr Pulmonol. 1996 Sep;22(3):188-94
    1. Eur J Pediatr. 1997 May;156(5):384-8
    1. Acta Paediatr Suppl. 1997 Apr;419:4-10
    1. Arch Pediatr Adolesc Med. 1999 Apr;153(4):331-8
    1. Lakartidningen. 1999 Mar 31;96(13):1571-6
    1. Arch Dis Child Fetal Neonatal Ed. 2000 Nov;83(3):F182-5

Source: PubMed

3
購読する